Nitric oxide-based therapies in sickle cell disease: The evidence continues to mount

Critical Care Medicine

Volumn 35, Issue 2, 2007, Pages 654-655

  Machado, Roberto F ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Acute chest syndrome; Arginase; Nitric oxide; Sepsis; Sickle cell disease; Vasoocclusive pain crisis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ACUTE CHEST SYNDROME; DOWN REGULATION; DRUG EFFECT; EDITORIAL; ENZYME REGULATION; HUMAN; INFLAMMATION; LEG ULCER; NONHUMAN; PATHOPHYSIOLOGY; PERITONITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPSIS; SICKLE CELL ANEMIA; SURVIVAL; VEIN OCCLUSION;

ANEMIA, SICKLE CELL; ANIMALS; NITRIC OXIDE;

EID: 33846440105     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000251844.19490.3B     Document Type: Editorial

References (16)

1. Serjeant GR: Sickle-cell disease. Lancet 1997; 350:725-730
2. Gladwin MT, Schechter AN, Shelhamer JH, et al: The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment. Am J Respir Crit Care Med 1999; 159:1368-1376
3. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2001; 2:907-916
4. Griffiths MJ, Evans TW: Inhaled nitric oxide therapy in adults. N Engl J Med 2005; 353: 2683-2695
5. Machado RF, Gladwin MT: Chronic sickle cell lung disease: New insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol 2005; 129:449-464
6. Reiter CD, Gladwin MT: An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol 2003; 10:99-107
7. Martinez-Ruiz R, Montero-Huerta P, Hromi J, et al: Inhaled nitric oxide improves survival rates during hypoxia in a sickle cell (SAD) mouse model. Anesthesiology 2001; 94:1113-1118
8. de Franceschi L, Baron A, Scarpa A, et al: Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood 2003; 102:1087-1096
9. Sullivan KJ, Goodwin SR, Evangelist J, et al: Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999; 27:2563-2568
10. Weiner DL, Hibberd PL, Betit P, et al: Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 2003; 289:1136-1142
11. Bartolucci P, Ngo MT, Beuzard Y, et al: Decrease in lung nitric oxide production after peritonitis in mice with sickle cell disease. Crit Care Med 2007; 35:502-509
12. Aslan M, Ryan TM, Adler B, et al: Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A 2001; 98:15215-15220
13. Reiter CD, Wang X, Tanus-Santos JE, et al: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8:1383-1389
14. Aslan M, Ryan TM, Townes TM, et al: Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 2003; 278:4194-4204
15. Hammerman SI, Klings ES, Hendra KP, et al: Endothelial cell nitric oxide production in acute chest syndrome. Am J Physiol 1999; 277:H1579-H1592
16. Kaul DK, Liu XD, Fabry ME, et al: Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 2000; 278:H1799-H1806